NYSE:DVA - Davita Stock Price, Price Target & More

$63.30 +0.45 (+0.72 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$63.30
Today's Range$61.92 - $63.4850
52-Week Range$52.51 - $80.71
Volume1.41 million shs
Average Volume1.55 million shs
Market Capitalization$11.48 billion
P/E Ratio19.07
Dividend YieldN/A
Beta1.09

About Davita (NYSE:DVA)

Davita logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:DVA
CUSIP23918K10
Phone303-405-2100

Debt

Debt-to-Equity Ratio1.87%
Current Ratio2.88%
Quick Ratio2.82%

Price-To-Earnings

Trailing P/E Ratio19.07
Forward P/E Ratio15.22
P/E Growth0.91

Sales & Book Value

Annual Sales$10.88 billion
Price / Sales1.06
Cash Flow$7.7289 per share
Price / Cash8.19
Book Value$26.66 per share
Price / Book2.37

Profitability

EPS (Most Recent Fiscal Year)$3.32
Net Income$663.61 million
Net Margins4.65%
Return on Equity12.86%
Return on Assets3.43%

Miscellaneous

Employees74,500
Outstanding Shares182,000,000

How to Become a New Pot Stock Millionaire

Davita (NYSE:DVA) Frequently Asked Questions

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How will Davita's stock buyback program work?

Davita declared that its board has initiated a stock buyback program on Wednesday, October 11th 2017, which allows the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its stock is undervalued.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) posted its earnings results on Tuesday, February, 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.94 by $0.02. The business had revenue of $2.78 billion for the quarter, compared to the consensus estimate of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same quarter in the prior year, the business posted $0.98 EPS. View Davita's Earnings History.

When is Davita's next earnings date?

Davita is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Davita.

What price target have analysts set for DVA?

11 Wall Street analysts have issued 1 year price objectives for Davita's stock. Their forecasts range from $60.00 to $97.00. On average, they anticipate Davita's share price to reach $79.00 in the next year. View Analyst Ratings for Davita.

Who are some of Davita's key competitors?

Who are Davita's key executives?

Davita's management team includes the folowing people:
  • Kent J. Thiry, Chairman of the Board (Age 61)
  • James K. Hilger, Interim Chief Financial Officer, Chief Accounting Officer (Age 55)
  • Joel Ackerman, Chief Financial Officer (Age 51)
  • Robert Lang, President, International Business
  • Javier J. Rodriguez, Chief Executive Officer - Kidney Care (Age 46)
  • Jeanine M. Jiganti, Chief Compliance Officer (Age 57)
  • LeAnne M. Zumwalt, Group Vice President - purchasing and government affairs (Age 58)
  • Kathleen Alyce Waters, Chief Legal Officer (Age 49)
  • Peter T. Grauer, Lead Director, Independent Director (Age 71)
  • Pamela M. Arway, Independent Director (Age 63)

Has Davita been receiving favorable news coverage?

News headlines about DVA stock have trended somewhat positive this week, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Davita earned a media sentiment score of 0.12 on Accern's scale. They also gave press coverage about the company an impact score of 45.29 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $63.30.

How big of a company is Davita?

Davita has a market capitalization of $11.48 billion and generates $10.88 billion in revenue each year. The company earns $663.61 million in net income (profit) each year or $3.32 on an earnings per share basis. Davita employs 74,500 workers across the globe.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 303-405-2100 or via email at [email protected]


MarketBeat Community Rating for Davita (DVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  333 (Vote Outperform)
Underperform Votes:  356 (Vote Underperform)
Total Votes:  689
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe DVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DVA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Davita (NYSE:DVA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Davita in the last 12 months. Their average twelve-month price target is $79.00, suggesting that the stock has a possible upside of 24.80%. The high price target for DVA is $97.00 and the low price target for DVA is $60.00. There are currently 1 sell rating, 4 hold ratings, 4 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.642.642.642.00
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $79.00$79.00$78.2222$65.00
Price Target Upside: 24.80% upside5.86% upside2.26% downside9.52% upside

Davita (NYSE:DVA) Consensus Price Target History

Price Target History for Davita (NYSE:DVA)

Davita (NYSE:DVA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/14/2018SunTrust BanksReiterated RatingHold$80.00MediumView Rating Details
2/13/2018Robert W. BairdSet Price TargetBuy$97.00HighView Rating Details
1/11/2018Bank of AmericaReiterated RatingBuy$85.00 -> $92.00HighView Rating Details
12/11/2017CitigroupUpgradeNeutral -> Buy$67.71 -> $82.00MediumView Rating Details
12/7/2017JPMorgan ChaseBoost Price TargetOutperform -> Strong-Buy$4.90 -> $84.00LowView Rating Details
12/7/2017Raymond JamesUpgradeOutperform -> Strong-Buy$65.00 -> $84.00HighView Rating Details
12/6/2017KeyCorpReiterated RatingHoldLowView Rating Details
11/8/2017Royal Bank of CanadaLower Price TargetSector Perform$64.00 -> $60.00N/AView Rating Details
10/23/2017Wolfe ResearchUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2017Jefferies GroupReiterated RatingHold$70.00MediumView Rating Details
5/25/2017Goldman SachsReiterated RatingSell$62.00HighView Rating Details
11/1/2016Wells FargoReiterated RatingOutperformN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Davita (NYSE:DVA) Earnings History and Estimates Chart

Earnings by Quarter for Davita (NYSE:DVA)

Davita (NYSE:DVA) Earnings Estimates

2018 EPS Consensus Estimate: $4.00
2019 EPS Consensus Estimate: $4.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.88$0.93$0.91
Q2 20182$0.95$1.04$1.00
Q3 20182$1.03$1.04$1.04
Q4 20182$1.01$1.12$1.07
Q1 20192$1.00$1.04$1.02
Q2 20192$1.06$1.15$1.11
Q3 20192$1.15$1.17$1.16
Q4 20192$1.16$1.22$1.19

Davita (NYSE DVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018$0.93N/AView Earnings Details
2/13/2018Q4 2017$0.94$0.92$3.8959 billion$2.7809 billionViewListenView Earnings Details
11/7/2017Q3 2017$0.94$0.81$3.9076 billion$3.9228 billionViewN/AView Earnings Details
8/1/2017Q2 2017$0.90$0.92$3.8170 billion$3.8775 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.8150$0.79$3.6882 billion$3.6973 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.7157 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.5336 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.5257 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.4346 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.2880 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.3280 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.2518 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.1725 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.0230 billion$3.0428 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$2.9996 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.8717 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.8296 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
5/1/2012Q1 2012$0.73$0.73ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
11/4/2010Q3 2010$0.57$0.57ViewN/AView Earnings Details
8/2/2010Q2 2010$0.54$0.53ViewN/AView Earnings Details
4/27/2010Q1 2010$0.52$0.52ViewN/AView Earnings Details
2/10/2010Q4 2009$0.53$0.53ViewN/AView Earnings Details
11/3/2009Q3 2009$0.50$0.53ViewN/AView Earnings Details
8/4/2009Q2 2009$0.48$0.51ViewN/AView Earnings Details
4/27/2009Q1 2009$0.45$0.46ViewN/AView Earnings Details
2/10/2009Q4 2008$0.45$0.47ViewN/AView Earnings Details
11/3/2008Q3 2008$0.44$0.44ViewN/AView Earnings Details
8/4/2008Q2 2008$0.42$0.45ViewN/AView Earnings Details
4/29/2008Q1 2008$0.39$0.40ViewN/AView Earnings Details
2/13/2008Q4 2007$0.40$0.40ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Davita (NYSE:DVA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Davita (NYSE DVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 85.77%
Insider Trading History for Davita (NYSE:DVA)
Institutional Ownership by Quarter for Davita (NYSE:DVA)

Davita (NYSE DVA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2018James K HilgerInsiderSell3,572$78.95$282,009.4033,649View SEC Filing  
12/11/2017Charles BergInsiderSell7,048$69.24$488,003.525,359View SEC Filing  
12/8/2017Kent J ThiryChairmanSell81,800$68.04$5,565,672.00View SEC Filing  
12/8/2017Leanne M ZumwaltVPSell949$68.19$64,712.3112,423View SEC Filing  
12/7/2017James K HilgerInsiderSell5,608$69.46$389,531.6847,649View SEC Filing  
12/7/2017Javier RodriguezCEOSell22,532$67.48$1,520,459.36210,317View SEC Filing  
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.7499,111View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.2034,719View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.6645,277View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.5852,279View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.415,716View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.007,590View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.8436,394View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.6429,147View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.2039,184View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.0018,766View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.048,585View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.9721,130View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.0464,264View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.4612,279View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.8018,324View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.0092,716View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.8436,665View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12317,397View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.6092,716View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.0036,070View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10120,816View SEC Filing  
1/13/2016Christopher James SchnarrInsiderBuy5,000$0.68$3,400.00
1/11/2016Christopher James SchnarrInsiderBuy10,000$0.60$6,000.00
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.608,447View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.767,438View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.0040,874View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00247,950View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.1813,277View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.0064,264View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.2859,624View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.6859,624View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.052,633View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.966,036View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.262,191,806View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.0081,766View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.034,994View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.016,036View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.072,508View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.161,095,903View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Davita (NYSE DVA) News Headlines

Source:
DateHeadline
How Highmark and a provider are working to lower the cost of dialysis careHow Highmark and a provider are working to lower the cost of dialysis care
finance.yahoo.com - April 24 at 5:38 PM
DaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve ...DaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve ...
www.prnewswire.com - April 24 at 8:16 AM
DaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve Transplant Readiness of PatientsDaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve Transplant Readiness of Patients
finance.yahoo.com - April 24 at 8:16 AM
DaVita Recognized as a LearningElite Company by Chief Learning Officer MagazineDaVita Recognized as a LearningElite Company by Chief Learning Officer Magazine
finance.yahoo.com - April 23 at 5:16 PM
DaVita Releases 10th Annual Community Care ReportDaVita Releases 10th Annual Community Care Report
finance.yahoo.com - April 19 at 8:12 AM
Buying Binge For UnitedHealths Optum Is Only Just BeginningBuying Binge For UnitedHealth's Optum Is Only Just Beginning
finance.yahoo.com - April 18 at 8:12 AM
Williamsville dialysis center plans new siteWilliamsville dialysis center plans new site
www.bizjournals.com - April 17 at 6:00 PM
ION Announces Executive Vice President, Corporate Compliance OfficerION Announces Executive Vice President, Corporate Compliance Officer
www.prnewswire.com - April 17 at 8:24 AM
UnitedHealth raises guidance after 31% profit riseUnitedHealth raises guidance after 31% profit rise
www.marketwatch.com - April 17 at 8:24 AM
[$$] UnitedHealth Increases Guidance for Year[$$] UnitedHealth Increases Guidance for Year
finance.yahoo.com - April 17 at 8:24 AM
Head-To-Head Survey: Davita (DVA) versus Caladrius Biosciences (CLBS)Head-To-Head Survey: Davita (DVA) versus Caladrius Biosciences (CLBS)
www.americanbankingnews.com - April 16 at 5:21 PM
Analyzing Davita (DVA) & Tivity Health (TVTY)Analyzing Davita (DVA) & Tivity Health (TVTY)
www.americanbankingnews.com - April 15 at 5:07 AM
 Brokerages Expect Davita Inc (DVA) Will Post Quarterly Sales of $2.94 Billion Brokerages Expect Davita Inc (DVA) Will Post Quarterly Sales of $2.94 Billion
www.americanbankingnews.com - April 15 at 4:45 AM
Davita (DVA) Stock Rating Reaffirmed by Jefferies GroupDavita (DVA) Stock Rating Reaffirmed by Jefferies Group
www.americanbankingnews.com - April 13 at 11:43 PM
Davita (DVA) Lowered to "C+" at TheStreetDavita (DVA) Lowered to "C+" at TheStreet
www.americanbankingnews.com - April 13 at 10:53 AM
Zacks: Brokerages Expect Davita Inc (DVA) to Announce $0.92 EPSZacks: Brokerages Expect Davita Inc (DVA) to Announce $0.92 EPS
www.americanbankingnews.com - April 13 at 9:01 AM
DaVita Certified as Freedom-Centered Workplace by WorldBluDaVita Certified as Freedom-Centered Workplace by WorldBlu
www.prnewswire.com - April 12 at 5:42 PM
Davita Inc (DVA) Given Consensus Rating of "Hold" by AnalystsDavita Inc (DVA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - April 12 at 1:34 AM
30,000 Strong and Counting, UnitedHealth Gathers a Doctor Army30,000 Strong and Counting, UnitedHealth Gathers a Doctor Army
finance.yahoo.com - April 9 at 8:14 AM
Davita (DVA) Downgraded by JPMorgan Chase to UnderweightDavita (DVA) Downgraded by JPMorgan Chase to Underweight
www.americanbankingnews.com - April 7 at 8:50 PM
Davita (DVA) Receives "Hold" Rating from KeyCorpDavita (DVA) Receives "Hold" Rating from KeyCorp
www.americanbankingnews.com - April 7 at 12:47 PM
Davita (DVA) PT Set at $57.00 by SunTrust BanksDavita (DVA) PT Set at $57.00 by SunTrust Banks
www.americanbankingnews.com - April 7 at 12:31 PM
DaVita Advocates for Organ Donors to Support Its Patients Transplant Goals during National Donate Life MonthDaVita Advocates for Organ Donors to Support Its Patients' Transplant Goals during National Donate Life Month
www.streetinsider.com - April 2 at 8:32 AM
Davita (DVA) Price Target Cut to $60.00 by Analysts at Royal Bank of CanadaDavita (DVA) Price Target Cut to $60.00 by Analysts at Royal Bank of Canada
www.americanbankingnews.com - April 1 at 11:24 AM
Davita (DVA) Price Target Cut to $66.00 by Analysts at Bank of AmericaDavita (DVA) Price Target Cut to $66.00 by Analysts at Bank of America
www.americanbankingnews.com - April 1 at 9:46 AM
Davita (DVA) Upgraded to "Buy" at Bank of AmericaDavita (DVA) Upgraded to "Buy" at Bank of America
www.americanbankingnews.com - March 30 at 4:33 PM
Specialized Health Services Stocks Research Reports Released on Acadia Healthcare, DaVita, MEDNAX, and Tivity ...Specialized Health Services Stocks' Research Reports Released on Acadia Healthcare, DaVita, MEDNAX, and Tivity ...
www.prnewswire.com - March 28 at 8:24 AM
 Analysts Anticipate Davita Inc (DVA) to Post $0.92 EPS Analysts Anticipate Davita Inc (DVA) to Post $0.92 EPS
www.americanbankingnews.com - March 27 at 9:14 AM
Davita Target of Unusually Large Options Trading (DVA)Davita Target of Unusually Large Options Trading (DVA)
www.americanbankingnews.com - March 22 at 7:16 AM
DaVita (DVA) Banks on Kidney Care Unit Amid Labor Union WoesDaVita (DVA) Banks on Kidney Care Unit Amid Labor Union Woes
finance.yahoo.com - March 21 at 5:41 PM
DaVita Kidney Care Shares Seasonal Recipes in New Simply Spring CookbookDaVita Kidney Care Shares Seasonal Recipes in New Simply Spring Cookbook
finance.yahoo.com - March 21 at 8:42 AM
Is DaVita (DVA) a Great Stock for Value Investors Right Now?Is DaVita (DVA) a Great Stock for Value Investors Right Now?
finance.yahoo.com - March 20 at 5:21 PM
Free Post Earnings Research Report: DaVita’s Quarterly Revenues Rose 3%; EPS Advanced 16%Free Post Earnings Research Report: DaVita’s Quarterly Revenues Rose 3%; EPS Advanced 16%
finance.yahoo.com - March 20 at 8:22 AM
Social Workers Play Vital Role in Patients Overall HealthSocial Workers Play Vital Role in Patients' Overall Health
finance.yahoo.com - March 20 at 8:22 AM
Renal Physicians Association Honors Dr. Robert Provenzano with Distinguished Nephrology Service AwardRenal Physicians Association Honors Dr. Robert Provenzano with Distinguished Nephrology Service Award
finance.yahoo.com - March 19 at 8:17 AM
Davita Inc (DVA) Receives Consensus Recommendation of "Hold" from BrokeragesDavita Inc (DVA) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 18 at 1:36 AM
Davita Sees Unusually Large Options Volume (DVA)Davita Sees Unusually Large Options Volume (DVA)
www.americanbankingnews.com - March 16 at 7:23 AM
DaVita Kidney Care Recognizes Its Dietitians on Registered ... - PR Newswire (press release)DaVita Kidney Care Recognizes Its Dietitians on Registered ... - PR Newswire (press release)
www.prnewswire.com - March 15 at 8:12 AM
DaVita Kidney Care Recognizes Its Dietitians on Registered Dietitian Nutritionist DayDaVita Kidney Care Recognizes Its Dietitians on Registered Dietitian Nutritionist Day
finance.yahoo.com - March 14 at 7:11 PM
DaVita Recognized for 11th Consecutive Year Among FORTUNE® Magazines Worlds Most Admired Companies® - PR Newswire (press release)DaVita Recognized for 11th Consecutive Year Among FORTUNE® Magazine's World's Most Admired Companies® - PR Newswire (press release)
www.prnewswire.com - March 12 at 8:42 AM
DaVita Recognized for 11th Consecutive Year Among FORTUNE® Magazines Worlds Most Admired Companies®DaVita Recognized for 11th Consecutive Year Among FORTUNE® Magazine's World's Most Admired Companies®
finance.yahoo.com - March 12 at 8:42 AM
Zacks: Brokerages Anticipate Davita Inc (DVA) Will Announce Earnings of $0.91 Per ShareZacks: Brokerages Anticipate Davita Inc (DVA) Will Announce Earnings of $0.91 Per Share
www.americanbankingnews.com - March 10 at 3:34 AM
See what the IHS Markit Score report has to say about Davita Inc.See what the IHS Markit Score report has to say about Davita Inc.
finance.yahoo.com - March 9 at 8:15 AM
DaVita Hosts Panel to Promote Womens Health and Empowerment on World Kidney Day - PR Newswire (press release)DaVita Hosts Panel to Promote Women's Health and Empowerment on World Kidney Day - PR Newswire (press release)
www.prnewswire.com - March 8 at 8:18 AM
DaVita Hosts Panel to Promote Womens Health and Empowerment on World Kidney DayDaVita Hosts Panel to Promote Women's Health and Empowerment on World Kidney Day
finance.yahoo.com - March 8 at 8:18 AM
DaVita Celebrates National Nutrition Month with Online Kidney Diet Resources - PR Newswire (press release)DaVita Celebrates National Nutrition Month with Online Kidney Diet Resources - PR Newswire (press release)
www.prnewswire.com - March 6 at 8:12 AM
DaVita Celebrates National Nutrition Month with Online Kidney Diet ResourcesDaVita Celebrates National Nutrition Month with Online Kidney Diet Resources
finance.yahoo.com - March 6 at 8:12 AM
Calamos Advisors LLC Sells 806 Shares of Davita Inc (DVA)Calamos Advisors LLC Sells 806 Shares of Davita Inc (DVA)
www.americanbankingnews.com - March 6 at 5:22 AM
Davita Inc (DVA) Shares Bought by American International Group Inc.Davita Inc (DVA) Shares Bought by American International Group Inc.
www.americanbankingnews.com - March 6 at 4:24 AM
Stonerise Capital Management LLC Buys New Position in Davita Inc (DVA)Stonerise Capital Management LLC Buys New Position in Davita Inc (DVA)
www.americanbankingnews.com - March 4 at 2:59 PM

SEC Filings

Davita (NYSE:DVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Davita (NYSE:DVA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Davita (NYSE DVA) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.